{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:09:21Z","timestamp":1789157361179,"version":"build-2803163510"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.mam.2026.101505","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:23:26Z","timestamp":1788787406000},"page":"101505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Decoding ctDNA: biological insights for accurate clinical interpretation"],"prefix":"10.1016","volume":"112","author":[{"given":"Mathieu","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen-Lise Garm","family":"Spindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3489-2479","authenticated-orcid":false,"given":"Zahra","family":"Eslami-S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Pantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6401-2903","authenticated-orcid":false,"given":"Catherine","family":"Alix-Panabi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7957","key":"10.1016\/j.mam.2026.101505_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-023-05776-4","article-title":"Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA","volume":"616","author":"Abbosh","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13073-026-01618-w","article-title":"Longitudinal cell-free DNA methylome and fragmentome profiles in health uncover signatures of cell type and demographic origin","volume":"18","author":"Aerden","year":"2026","journal-title":"Genome Med."},{"key":"10.1016\/j.mam.2026.101505_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.omtn.2020.01.035","article-title":"Targeting circulating SINEs and LINEs with DNase I provides metastases inhibition in experimental tumor models","volume":"20","author":"Alekseeva","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.mam.2026.101505_bib4","article-title":"Advances in liquid biopsy: from exploration to practical application","author":"Alix-Panabi\u00e8res","year":"2024","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.mam.2026.101505_bib5","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3390\/cells10102667","article-title":"Neutrophil extracellular Traps-DNase balance and autoimmunity","volume":"10","author":"Angeletti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mam.2026.101505_bib6","article-title":"Effects of metastatic sites on circulating tumor DNA in patients with metastatic colorectal cancer","volume":"6","author":"Bando","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.mam.2026.101505_bib7","doi-asserted-by":"crossref","unstructured":"Banerjee S, Shende SS, Kata L, Lopes RS, Praveen S, Joshi R, et al. Horizontally transferred cell-free chromatin particles function as autonomous \u2018satellite genomes\u2019 and vehicles for transposable elements within host cells. eLife. 13:RP103771. doi:10.7554\/eLife.103771 PubMed PMID: 40953126; PubMed Central PMCID: PMC12435896.","DOI":"10.7554\/eLife.103771"},{"key":"10.1016\/j.mam.2026.101505_bib8","first-page":"12","article-title":"Detection of cell types contributing to cancer from circulating, cell-free methylated DNA","volume":"27","author":"Barefoot","year":"2021","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/biology9010021","article-title":"Apoptotic bodies: particular extracellular vesicles involved in intercellular communication","volume":"9","author":"Battistelli","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.mam.2026.101505_bib10","unstructured":"Benchmarking UMI-aware and standard variant callers for low frequency ctDNA variant detection | BMC Genomics | Springer Nature Link [Internet]. [cited 2026 Aug 27]. Available from: https:\/\/link.springer.com\/article\/10.1186\/s12864-024-10737-w?utm_source=chatgpt.com."},{"issue":"224","key":"10.1016\/j.mam.2026.101505_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in Early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"224","key":"10.1016\/j.mam.2026.101505_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in Early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib13","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"15","key":"10.1016\/j.mam.2026.101505_bib14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/cells14151200","article-title":"Dual Nature of neutrophil extracellular traps (NETs)-From cancer's ally to therapeutic target","volume":"14","author":"Buszka","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.mam.2026.101505_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.103066","article-title":"Clinical performance of tumor-informed versus tumor-agnostic ctDNA assays for colorectal cancer recurrence: a systematic review and diagnostic accuracy meta-analysis","volume":"142","author":"Camblor","year":"2026","journal-title":"Cancer Treat Rev."},{"issue":"10","key":"10.1016\/j.mam.2026.101505_bib16","article-title":"The circulating cell-free DNA landscape in sepsis is dominated by impaired liver clearance","volume":"5","author":"Cano-Gamez","year":"2025","journal-title":"Cell Genom."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1703244","article-title":"Inhibiting extracellular vesicles formation and release: a review of EV inhibitors","volume":"9","author":"Catalano","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.mam.2026.101505_bib19","article-title":"Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients","volume":"12","author":"Chan","year":"2022","journal-title":"Front. Oncol."},{"issue":"15","key":"10.1016\/j.mam.2026.101505_bib18","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1158\/1078-0432.CCR-08-1112","article-title":"Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients","volume":"14","author":"Chan","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib20","article-title":"Chemotherapy-induced DNA release modulates antitumor immune response","volume":"16","year":"2026","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.mam.2026.101505_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104554","article-title":"Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA","volume":"25","author":"Cheng","year":"2022","journal-title":"iScience"},{"issue":"10","key":"10.1016\/j.mam.2026.101505_bib22","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.bpj.2018.03.015","article-title":"Major determinants of nucleosome positioning","volume":"114","author":"Chereji","year":"2018","journal-title":"Biophys. J."},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40291-019-00390-5","article-title":"Detection of solid tumor Molecular Residual Disease (MRD) using circulating tumor DNA (ctDNA)","volume":"23","author":"Chin","year":"2019","journal-title":"Mol. Diagn. Ther."},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.yexmp.2018.07.007","article-title":"Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme","volume":"105","author":"Chistiakov","year":"2018","journal-title":"Exp. Mol. Pathol."},{"issue":"13","key":"10.1016\/j.mam.2026.101505_bib25","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1093\/nar\/gkae427","article-title":"Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells","volume":"52","author":"Cinar","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13059-020-02179-w","article-title":"Do malignant cells sleep at night?","volume":"21","author":"Cort\u00e9s-Hern\u00e1ndez","year":"2020","journal-title":"Genome Biol."},{"issue":"6","key":"10.1016\/j.mam.2026.101505_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000572","article-title":"Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients","volume":"4","author":"Crisafulli","year":"2019","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41698-021-00198-9","article-title":"A DNA methylation-based liquid biopsy for triple-negative breast cancer","volume":"5","author":"Cristall","year":"2021","journal-title":"npj Precis. Oncol."},{"issue":"8_Suppl. ment_1","key":"10.1016\/j.mam.2026.101505_bib29","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/1538-7445.AM2025-3259","article-title":"Abstract 3259: beyond tumor size: biological and clinical predictors of ctDNA shedding in colon cancer","volume":"85","author":"Crnovsanin","year":"2025","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.mam.2026.101505_bib47","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1101\/gad.192351.112","article-title":"Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers","volume":"26","author":"D'Souza-Schorey","year":"2012","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.mam.2026.101505_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154941","article-title":"Circulating tumor DNA: current challenges for clinical utility","volume":"132","author":"Dang","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mam.2026.101505_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13059-022-02791-y","article-title":"Dissemination of circulating tumor cells at night: role of sleep or circadian rhythm?","volume":"23","author":"Dauvilliers","year":"2022","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s42003-024-06129-1","article-title":"An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release","volume":"7","author":"Davidson","year":"2024","journal-title":"Commun. Biol."},{"issue":"4","key":"10.1016\/j.mam.2026.101505_bib33","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026880","article-title":"Characterizing the cancer genome in blood","volume":"9","author":"Dawson","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tips.2019.01.006","article-title":"Liquid biopsies in cancer diagnosis, monitoring, and prognosis","volume":"40","author":"De","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mam.2026.101505_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105636","article-title":"Reporting of molecular test results from cell-free DNA analyses: expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA Workshop","volume":"114","author":"de Jager","year":"2025","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11033-023-09016-w","article-title":"The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer","volume":"51","author":"De La Cruz-Sig\u00fcenza","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib37","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/2159-8290.CD-22-0692","article-title":"Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes","volume":"13","author":"De Sarkar","year":"2023","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/2159-8290.CD-22-0692","article-title":"Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes","volume":"13","author":"De Sarkar","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mam.2026.101505_bib39","article-title":"Reference materials and external quality assessment for liquid biopsy assays: expert opinions from the European Liquid Biopsy Society ctDNA workshop","volume":"47","author":"Deans","year":"2026","journal-title":"Cancer Treat Res Commun"},{"issue":"9","key":"10.1016\/j.mam.2026.101505_bib40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/s41587-021-00857-z","article-title":"Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology","volume":"39","author":"Deveson","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.mam.2026.101505_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/bjs.11310","article-title":"Dysregulation of the actin scavenging system and inhibition of DNase activity following severe thermal injury","volume":"107","author":"Dinsdale","year":"2020","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib42","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1038\/s41467-022-35076-w","article-title":"A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA","volume":"13","author":"Doebley","year":"2022","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.mam.2026.101505_bib43","doi-asserted-by":"crossref","first-page":"6258","DOI":"10.3390\/ijms22126258","article-title":"Pro-Inflammatory microenvironment modulates the transfer of mutated TP53 mediated by tumor exosomes","volume":"22","author":"Domenis","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib44","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2274123","article-title":"Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article","volume":"24","author":"Dong","year":"2023","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib45","first-page":"403","article-title":"Chromatin clearance in C57Bl\/10 mice: interaction with heparan sulphate proteoglycans and receptors on Kupffer cells","volume":"117","author":"Du","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.mam.2026.101505_bib46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fimmu.2019.00502","article-title":"Cell-free DNA as a biomarker in autoimmune rheumatic diseases","volume":"10","author":"Duvvuri","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2026.101505_bib48","first-page":"10","article-title":"The metastatic Cascade as the basis for liquid biopsy development","volume":"21","author":"Eslami-S","year":"2020","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.mam.2026.101505_bib49","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037333","article-title":"The different facets of liquid biopsy: a kaleidoscopic view","volume":"10","author":"Eslami-S","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.mam.2026.101505_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231220607","article-title":"Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I-IV colorectal cancer","volume":"16","author":"Fan","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"8","key":"10.1016\/j.mam.2026.101505_bib51","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1373\/clinchem.2018.290304","article-title":"Liver- and colon-specific DNA methylation markers in plasma for investigation of colorectal cancers with or without liver metastases","volume":"64","author":"Gai","year":"2018","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.mam.2026.101505_bib52","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/cancers16040782","article-title":"Variant allele frequency analysis of circulating tumor DNA as a promising tool in assessing the effectiveness of treatment in non-small cell lung carcinoma patients","volume":"16","author":"Galant","year":"2024","journal-title":"Cancers"},{"issue":"16_Suppl. l","key":"10.1016\/j.mam.2026.101505_bib53","article-title":"Minimal residual disease (MRD) assessment by circulating tumor DNA (ctDNA) to stratify recurrence risk and adjuvant treatment benefit in a real-world colorectal cancer (CRC) cohort","volume":"44","author":"Galuia","year":"2026","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib54","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/0008-5472.CAN-09-3513","article-title":"Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells","volume":"70","author":"Garc\u00eda-Olmo","year":"2010","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.mam.2026.101505_bib55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3892\/ijmm.2024.5366","article-title":"Methylation-sensitive restriction enzyme-droplet digital PCR assay for the one-step highly sensitive analysis of DNA methylation hotspots","volume":"53","author":"Gattuso","year":"2024","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.mam.2026.101505_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2024.14681","article-title":"Liquid biopsy: comprehensive overview of circulating tumor DNA","volume":"28","author":"Ge","year":"2024","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jmoldx.2015.02.001","article-title":"Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology","volume":"17","author":"Gold","year":"2015","journal-title":"J Mol Diagn JMD"},{"issue":"5","key":"10.1016\/j.mam.2026.101505_bib58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3892\/mco.2022.2533","article-title":"Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer","volume":"16","author":"Gong","year":"2022","journal-title":"Mol. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.mam.2026.101505_bib59","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1007\/s00259-021-05306-2","article-title":"Cell-free DNA concentration and fragment size fraction correlate with FDG PET\/CT-derived parameters in NSCLC patients","volume":"48","author":"Gonz\u00e1lez de Aledo-Castillo","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.annonc.2023.12.007","article-title":"Liquid biopsy response evaluation criteria in solid tumors (LB-RECIST)","volume":"35","author":"Gouda","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mam.2026.101505_bib61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s40364-024-00661-2","article-title":"The detection, biological function, and liquid biopsy application of extracellular vesicle-associated DNA","volume":"12","author":"Guo","year":"2024","journal-title":"Biomark. Res."},{"issue":"6","key":"10.1016\/j.mam.2026.101505_bib62","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/2159-8290.CD-13-1014","article-title":"Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA","volume":"4","author":"Haber","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mam.2026.101505_bib63","series-title":"Psycho-Oncology [Internet]","article-title":"Psychosocial issues related to liquid biopsy for ctDNA in individuals at normal and elevated risk","author":"Hamilton","year":"2021"},{"issue":"8","key":"10.1016\/j.mam.2026.101505_bib64","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.tig.2021.04.005","article-title":"The nexus of cfDNA and nuclease biology","volume":"37","author":"Han","year":"2021","journal-title":"Trends Genet."},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ajhg.2020.01.008","article-title":"The biology of cell-free DNA fragmentation and the roles of DNASE1, DNASE1L3, and DFFB","volume":"106","author":"Han","year":"2020","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.mam.2026.101505_bib66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.molmed.2020.01.012","article-title":"Cell-free DNA and apoptosis: how dead cells inform about the living","volume":"26","author":"Heitzer","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mam.2026.101505_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fmed.2018.00009","article-title":"Liquid biopsy in clinical management of breast, lung, and colorectal cancer","volume":"5","author":"Hench","year":"2018","journal-title":"Front. Med."},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib68","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1078-0432.CCR-21-2404","article-title":"Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, toward assessment of adjuvant therapy efficacy and clinical behavior of recurrences","volume":"28","author":"Henriksen","year":"2022","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-med-100223-090016","article-title":"Circulating tumor DNA: a pan-cancer biomarker in solid tumors with prognostic and predictive value","volume":"76","author":"Hitchen","year":"2025","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.mam.2026.101505_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101735","article-title":"Matched tissue and liquid biopsies for advanced non-small cell lung cancer patients A potentially indispensable complementary approach","volume":"35","author":"Hofman","year":"2023","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.mam.2026.101505_bib71","article-title":"Biological fragmentation of circulating cell-free DNA alters genetic representation","volume":"1","author":"Hsiung","year":"2020","journal-title":"Curr Trends Clin Med Sci"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13148-023-01574-x","article-title":"Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity","volume":"15","author":"Hu","year":"2023","journal-title":"Clin Epigenetics"},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib74","article-title":"Holistic determination of ends of cfDNA molecules","volume":"6","author":"Jiang","year":"2026","journal-title":"Cell Genom."},{"issue":"5","key":"10.1016\/j.mam.2026.101505_bib73","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-19-0622","article-title":"Plasma DNA end-motif profiling as a fragmentomic marker in cancer, pregnancy, and transplantation","volume":"10","author":"Jiang","year":"2020","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.mam.2026.101505_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.gassur.2026.102411","article-title":"The role of circulating tumor DNA in precision adjuvant therapy for colorectal cancer: a scoping review","volume":"30","author":"Jiang","year":"2026","journal-title":"J. Gastrointest. Surg."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib76","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11357-022-00590-8","article-title":"Circulating cell-free DNA in health and disease \u2014 the relationship to health behaviours, ageing phenotypes and metabolomics","volume":"45","author":"Kananen","year":"2023","journal-title":"GeroScience"},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib77","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41416-020-01047-5","article-title":"Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond","volume":"124","author":"Keller","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.mam.2026.101505_bib78","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40291-021-00554-2","article-title":"Hepatic clearance of cell-free DNA: possible impact on early metastasis diagnosis","volume":"25","author":"Khier","year":"2021","journal-title":"Mol. Diagn. Ther."},{"issue":"6","key":"10.1016\/j.mam.2026.101505_bib79","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5306\/wjco.v13.i6.473","article-title":"Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies","volume":"13","author":"Kirchweger","year":"2022","journal-title":"World J. Clin. Oncol."},{"issue":"4_Suppl. l","key":"10.1016\/j.mam.2026.101505_bib80","article-title":"Association of circulating tumor DNA dynamics with clinical outcomes in the adjuvant setting for patients with colorectal cancer from an observational GALAXY study in CIRCULATE-Japan","volume":"40","author":"Kotaka","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0319194","article-title":"The role of renal and liver function in clinical ctDNA testing","volume":"20","author":"Koudahl Conrad","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19336918.2024.2395807","article-title":"Liquid biopsy: paving a new avenue for cancer research","volume":"18","author":"Kurma","year":"2024","journal-title":"Cell Adhes Migr"},{"issue":"8","key":"10.1016\/j.mam.2026.101505_bib83","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/15384047.2019.1598759","article-title":"Life and death of circulating cell-free DNA","volume":"20","author":"Kustanovich","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.mam.2026.101505_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.855463","article-title":"Proof-of-Concept pilot Study on comprehensive spatiotemporal intra-patient heterogeneity for colorectal cancer with liver metastasis","volume":"12","author":"Kyrochristos","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib85","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1373\/clinchem.2019.306837","article-title":"Multicenter evaluation of circulating cell-free DNA extraction and downstream analyses for the development of standardized (pre)analytical work flows","volume":"66","author":"Lampignano","year":"2020","journal-title":"Clin. Chem."},{"issue":"14","key":"10.1016\/j.mam.2026.101505_bib86","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/pros.22853","article-title":"Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes","volume":"74","author":"L\u00e1zaro-Ib\u00e1\u00f1ez","year":"2014","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.mam.2026.101505_bib87","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s12276-023-01069-y","article-title":"Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mam.2026.101505_bib89","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40779-025-00668-2","article-title":"Cell-free DNA in sepsis: from molecular insights to clinical management","volume":"12","author":"Li","year":"2025","journal-title":"Milit. Med. Res."},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib88","first-page":"108","article-title":"Advance and challenge of DNA methylation as cancer biomarkers for risk stratification, screening and early detection","volume":"5","author":"Li","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"issue":"9","key":"10.1016\/j.mam.2026.101505_bib90","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41585-025-01023-9","article-title":"Circulating tumour DNA and circulating tumour cells in bladder cancer \u2014 from discovery to clinical implementation","volume":"22","author":"Lindskrog","year":"2025","journal-title":"Nat. Rev. Urol."},{"issue":"10","key":"10.1016\/j.mam.2026.101505_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114799","article-title":"GWAS shows the genetics behind cell-free DNA and highlights the importance of p.Arg206Cys in DNASE1L3 for non-invasive testing","volume":"43","author":"Linthorst","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.mam.2026.101505_bib92","article-title":"Circulating cell-free DNA fragmentomics detection and beyond","author":"Liu","year":"2025","journal-title":"Aging Dis"},{"issue":"8","key":"10.1016\/j.mam.2026.101505_bib93","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/clinchem\/46.8.1039","article-title":"Molecular testing of urine: catching DNA on the way out","volume":"46","author":"Lo","year":"2000","journal-title":"Clin. Chem."},{"issue":"6538","key":"10.1016\/j.mam.2026.101505_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw3616","article-title":"Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies","volume":"372","author":"Lo","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib95","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-022-01543-7","article-title":"Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments","volume":"21","author":"Lone","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib96","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-022-01543-7","article-title":"Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments","volume":"21","author":"Lone","year":"2022","journal-title":"Mol. Cancer"},{"issue":"7943","key":"10.1016\/j.mam.2026.101505_bib97","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41586-022-05580-6","article-title":"A DNA methylation atlas of normal human cell types","volume":"613","author":"Loyfer","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.mam.2026.101505_bib99","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40364-025-00796-w","article-title":"Circulating tumor DNA for MRD detection in colorectal cancer: recent advances and clinical implications","volume":"13","author":"Ma","year":"2025","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib98","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer: current status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1101\/gr.279667.124","article-title":"Analysis of a cell-free DNA-based cancer screening cohort links fragmentomic profiles, nuclease levels, and plasma DNA concentrations","volume":"35","author":"Malki","year":"2025","journal-title":"Genome Res."},{"key":"10.1016\/j.mam.2026.101505_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.869706","article-title":"Extracellular DNA traps: origin, function and implications for anti-cancer therapies","volume":"12","author":"Mamtimin","year":"2022","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.mam.2026.101505_bib102","doi-asserted-by":"crossref","DOI":"10.1200\/PO-25-00287","article-title":"Variability of circulating tumor DNA levels in plasma samples from patients with advanced Non\u2013Small-cell lung cancer in the absence of treatment","author":"Markovets","year":"2025","journal-title":"JCO Precis. Oncol."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib103","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/s41598-022-05606-z","article-title":"Refined characterization of circulating tumor DNA through biological feature integration","volume":"12","author":"Markus","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2026.101505_bib104","article-title":"Implementing the European society for medical oncology scale for clinical actionability of molecular targets in a comprehensive profiling program: impact on precision medicine oncology","volume":"6","author":"Martin-Romano","year":"2022","journal-title":"JCO Precis. Oncol."},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/genes12030349","article-title":"Liquid biopsies: applications for cancer diagnosis and monitoring","volume":"12","author":"Martins","year":"2021","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib106","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1038\/s41467-021-24994-w","article-title":"Detection and characterization of lung cancer using cell-free DNA fragmentomes","volume":"12","author":"Mathios","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib107","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s42003-022-03755-5","article-title":"Structural features of Dnase1L3 responsible for serum antigen clearance","volume":"5","author":"McCord","year":"2022","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib108","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1186\/s12885-018-4637-6","article-title":"Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients","volume":"18","author":"McEvoy","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2017.15","article-title":"Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation","volume":"3","author":"Mittra","year":"2017","journal-title":"Cell Death Discov."},{"issue":"12","key":"10.1016\/j.mam.2026.101505_bib110","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1158\/2159-8290.CD-21-0634","article-title":"Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease","volume":"11","author":"Moding","year":"2021","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.mam.2026.101505_bib111","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.annonc.2024.04.005","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO precision medicine working group","volume":"35","author":"Mosele","year":"2024","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"3_Suppl. l","key":"10.1016\/j.mam.2026.101505_bib112","article-title":"Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively treated gastrointestinal cancers with microscopic residual disease","volume":"42","author":"Mukherji","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.mam.2026.101505_bib113","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.3390\/biomedicines10112853","article-title":"Cell-free DNA in the pathogenesis and therapy of non-infectious inflammations and tumors","volume":"10","author":"M\u0171zes","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib114","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13148-021-01095-5","article-title":"Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction","volume":"13","author":"Nassar","year":"2021","journal-title":"Clin Epigenetics"},{"issue":"6","key":"10.1016\/j.mam.2026.101505_bib115","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1113\/EP092167","article-title":"Assessing the exercise-related kinetics of circulating cell-free DNA, circulating tumour DNA, DNase I activity and cytokines in patients with solid tumours: a pilot study","volume":"111","author":"Neuberger","year":"2026","journal-title":"Exp. Physiol."},{"issue":"11","key":"10.1016\/j.mam.2026.101505_bib116","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/curroncol32110589","article-title":"ctDNA in pancreatic adenocarcinoma: a critical appraisal","volume":"32","author":"Ojha","year":"2025","journal-title":"Curr. Oncol."},{"issue":"9","key":"10.1016\/j.mam.2026.101505_bib117","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.molmed.2010.07.001","article-title":"Circulating tumour cells in cancer patients: challenges and perspectives","volume":"16","author":"Pantel","year":"2010","journal-title":"Trends Mol. Med."},{"issue":"12","key":"10.1016\/j.mam.2026.101505_bib118","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005615","article-title":"Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation","volume":"10","author":"Pantel","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mam.2026.101505_bib119","first-page":"156","article-title":"Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS)","volume":"44","author":"Pantel","year":"2025","journal-title":"J Exp Clin Cancer Res CR"},{"key":"10.1016\/j.mam.2026.101505_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1374816","article-title":"Circulating tumour DNA detects somatic variants contributing to spatial and temporal intra-tumoural heterogeneity in head and neck squamous cell carcinoma","volume":"14","author":"Payne","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mam.2026.101505_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103109","article-title":"ctDNA as a cancer biomarker: a broad overview","volume":"155","author":"Pessoa","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"49","key":"10.1016\/j.mam.2026.101505_bib122","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1038\/s41388-025-03624-5","article-title":"From concept to clinic: a roadmap for DNA methylation biomarkers in liquid biopsies","volume":"44","author":"Pharo","year":"2025","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47851-w","article-title":"Circadian rhythm and circulating cell-free DNA release on healthy subjects","volume":"13","author":"Poulet","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.mam.2026.101505_bib124","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/cancers16050844","article-title":"Modeling the effect of spatial structure on solid tumor evolution and circulating tumor DNA composition","volume":"16","author":"Rachman","year":"2024","journal-title":"Cancers"},{"issue":"8_Suppl. ment_1","key":"10.1016\/j.mam.2026.101505_bib125","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1158\/1538-7445.AM2025-3695","article-title":"Abstract 3695: a mechanistic model of ctDNA shedding and its relevance for clinical interpretation","volume":"85","author":"Rachman","year":"2025","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.mam.2026.101505_bib126","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.euo.2025.09.012","article-title":"The impact of kidney, liver, and immune function on circulating tumor DNA detection in muscle-invasive bladder cancer","volume":"8","author":"Radif","year":"2025","journal-title":"Eur. Urol. Oncol."},{"issue":"6","key":"10.1016\/j.mam.2026.101505_bib127","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.euo.2025.09.012","article-title":"The impact of kidney, liver, and immune function on circulating tumor DNA detection in muscle-invasive bladder cancer","volume":"8","author":"Radif","year":"2025","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.mam.2026.101505_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.943253","article-title":"Circulating Tumor DNA as a cancer biomarker: an overview of biological features and factors that may impact on ctDNA analysis","volume":"12","author":"S\u00e1nchez-Herrero","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.mam.2026.101505_bib129","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s44321-024-00082-6","article-title":"Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma","volume":"16","author":"Sementsov","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mam.2026.101505_bib130","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89321.3","article-title":"What fraction of cellular DNA turnover becomes cfDNA?","volume":"12","author":"Sender","year":"2024","journal-title":"eLife"},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib131","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1073\/pnas.1815031116","article-title":"Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA","volume":"116","author":"Serpas","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mam.2026.101505_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1629620","article-title":"Targeting ferroptosis, pyroptosis and necroptosis for cancer immunotherapy in melanoma: mechanistic insights and clinical perspectives","volume":"16","author":"Shan","year":"2025","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.mam.2026.101505_bib133","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.3390\/cancers15153970","article-title":"Circulating tumor DNA in head and neck squamous cell carcinoma: association with metabolic tumor burden determined with FDG-PET\/CT","volume":"15","author":"Silvoniemi","year":"2023","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.mam.2026.101505_bib134","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41551-021-00837-3","article-title":"Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics","volume":"6","author":"Song","year":"2022","journal-title":"Nat. Biomed. Eng."},{"issue":"12","key":"10.1016\/j.mam.2026.101505_bib137","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1002\/ijc.28946","article-title":"Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer","volume":"135","author":"Spindler","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mam.2026.101505_bib136","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231171580","article-title":"Circulating tumor DNA: response Evaluation Criteria in Solid Tumors - can we RECIST? Focus on colorectal cancer","volume":"15","author":"Spindler","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"14","key":"10.1016\/j.mam.2026.101505_bib138","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.177003","article-title":"A dual-acting DNASE1\/DNASE1L3 biologic prevents autoimmunity and death in genetic and induced lupus models","volume":"9","author":"Stabach","year":"2024","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.mam.2026.101505_bib139","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/jpm11060518","article-title":"Precision medicine in oncology: a review of multi-tumor actionable molecular targets with an emphasis on non-small cell lung cancer","volume":"11","author":"Stein","year":"2021","journal-title":"J Pers Med"},{"issue":"22","key":"10.1016\/j.mam.2026.101505_bib140","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1158\/1078-0432.CCR-25-0758","article-title":"The prognostic impact of early ctDNA kinetics in metastatic pancreatic cancer using the ctDNA-RECIST","volume":"31","author":"Steiniche","year":"2025","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"5","key":"10.1016\/j.mam.2026.101505_bib141","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ijc.32586","article-title":"Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma","volume":"146","author":"Strijker","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib142","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1245\/s10434-022-12399-y","article-title":"Circulating Tumor DNA is unreliable to detect somatic gene alterations in gastrointestinal peritoneal carcinomatosis","volume":"30","author":"Sullivan","year":"2023","journal-title":"Ann. Surg Oncol."},{"issue":"8","key":"10.1016\/j.mam.2026.101505_bib143","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s10147-021-01937-5","article-title":"Perspectives for circulating tumor DNA in clinical management of colorectal cancer","volume":"26","author":"Takemasa","year":"2021","journal-title":"Int. J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.mam.2026.101505_bib144","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41416-023-02445-1","article-title":"Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors","volume":"129","author":"Thompson","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00068-018-0954-3","article-title":"The source of cell-free mitochondrial DNA in trauma and potential therapeutic strategies","volume":"44","author":"Thurairajah","year":"2018","journal-title":"Eur J Trauma Emerg Surg Off Publ Eur Trauma Soc"},{"key":"10.1016\/j.mam.2026.101505_bib146","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-079126","article-title":"Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study","volume":"386","author":"Tibau","year":"2024","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib147","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaf584","article-title":"Imbalance between serum DNase-I protein levels and enzymatic activity in SLE: link with mitochondrial-DNA and low-density granulocytes","volume":"65","author":"Tob\u00edo-Parada","year":"2026","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib148","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14737159.6.2.153","article-title":"Transrenal DNA testing: progress and perspectives","volume":"6","author":"Umansky","year":"2006","journal-title":"Expert Rev. Mol. Diagn"},{"issue":"7","key":"10.1016\/j.mam.2026.101505_bib150","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/clinchem\/hvac069","article-title":"Dutch national round robin trial on plasma-derived circulating cell-free DNA extraction methods routinely used in clinical pathology for molecular tumor profiling","volume":"68","author":"van der Leest","year":"2022","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib149","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/clinchem\/hvad194","article-title":"Critical factors in the analytical work flow of circulating tumor DNA-Based molecular profiling","volume":"70","author":"van der Leest","year":"2024","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.mam.2026.101505_bib151","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.mam.2026.101505_bib154","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1515\/cclm-2023-1327","article-title":"Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management","volume":"62","author":"Wang","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"issue":"12","key":"10.1016\/j.mam.2026.101505_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108271","article-title":"Modeling early treatment response in AML from cell-free tumor DNA","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.mam.2026.101505_bib153","article-title":"Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.mam.2026.101505_bib155","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3390\/cancers12061588","article-title":"Technical evaluation of commercial mutation analysis platforms and reference materials for liquid biopsy profiling","volume":"12","author":"Weber","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.mam.2026.101505_bib156","first-page":"377","article-title":"Plasma biomarkers to study mechanisms of liver injury in patients with hypoxic hepatitis","volume":"37","author":"Weemhoff","year":"2017","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"5","key":"10.1016\/j.mam.2026.101505_bib157","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/cancers14051309","article-title":"Transcending blood-opportunities for alternate liquid biopsies in oncology","volume":"14","author":"Werner","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.mam.2026.101505_bib158","article-title":"Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA","volume":"1","author":"Willey","year":"2021","journal-title":"Cell Rep. Methods"},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib159","first-page":"e415","article-title":"Review of blood-based colorectal cancer screening: how far are circulating cell-free DNA methylation markers from clinical implementation?","volume":"17","author":"Worm \u00d8rntoft","year":"2018","journal-title":"Clin. Colorectal Cancer"},{"issue":"5","key":"10.1016\/j.mam.2026.101505_bib160","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/1878-0261.13357","article-title":"Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC","volume":"17","author":"Wu","year":"2023","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib161","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1038\/s41467-025-61890-z","article-title":"Cell-free DNA testing for the detection and prognosis prediction of pancreatic cancer","volume":"16","author":"Wu","year":"2025","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.mam.2026.101505_bib162","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s11912-025-01725-8","article-title":"From early detection to advanced therapies: how circulating tumor DNA is transforming the care of colorectal cancer","volume":"27","author":"Yee","year":"2025","journal-title":"Curr. Oncol. Rep."},{"issue":"2","key":"10.1016\/j.mam.2026.101505_bib163","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/clinchem\/hvac180","article-title":"Comparison of single molecule, real-time sequencing and nanopore sequencing for analysis of the size, End-Motif, and tissue-of-origin of long cell-free DNA in plasma","volume":"69","author":"Yu","year":"2023","journal-title":"Clin. Chem."},{"issue":"2_Suppl. l","key":"10.1016\/j.mam.2026.101505_bib164","article-title":"Pathologic determinants of ctDNA-shedding in colorectal cancer metastases","volume":"44","author":"Yukami","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mam.2026.101505_bib165","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69679","article-title":"The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma","volume":"10","author":"Yuwono","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.mam.2026.101505_bib166","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69679","article-title":"The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma","volume":"10","author":"Yuwono","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.mam.2026.101505_bib167","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69679","article-title":"The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma","volume":"10","author":"Yuwono","year":"2021","journal-title":"eLife"},{"issue":"13","key":"10.1016\/j.mam.2026.101505_bib168","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3390\/cancers17132172","article-title":"MicroRNAs in cancer immunology: master regulators of the tumor microenvironment and immune evasion, with therapeutic potential","volume":"17","author":"Zare","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.mam.2026.101505_bib169","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12964-025-02522-3","article-title":"DECIPHER-PRAD: an advanced fragmentomics-based cell-free DNA assay for prostate cancer early detection","volume":"24","author":"Zhang","year":"2025","journal-title":"Cell Commun. Signal."},{"issue":"17","key":"10.1016\/j.mam.2026.101505_bib170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220982120","article-title":"Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs","volume":"120","author":"Zhou","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"51","key":"10.1016\/j.mam.2026.101505_bib171","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj1397","article-title":"NET formation is a default epigenetic program controlled by PAD4 in apoptotic neutrophils","volume":"9","author":"Zhu","year":"2023","journal-title":"Sci. Adv."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299726000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299726000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:30:05Z","timestamp":1789155005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299726000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":171,"alternative-id":["S0098299726000610"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2026.101505","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding ctDNA: biological insights for accurate clinical interpretation","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2026.101505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101505"}}